Thank you, Mr. Chair.
I'd be happy to entertain that. One thing that I think we'd have to revisit is the actual schedule we have for the pharmacare study. I don't have it firmly in my mind right now how many more meetings and how many more witnesses we have.
I actually think that maybe we should schedule some committee business time next week for that. I don't think this is urgent. I think we can take some time to do that. I'd like to know who the witnesses are and what the category of testimony is to determine whether or not the committee would need to hear from them.